Purple Biotech (PPBT) Retained Earnings (2017 - 2021)

Purple Biotech (PPBT) has disclosed Retained Earnings for 5 consecutive years, with -$95.9 million as the latest value for Q4 2021.

  • On a quarterly basis, Retained Earnings fell 23.71% to -$95.9 million in Q4 2021 year-over-year; TTM through Dec 2021 was -$95.9 million, a 23.71% decrease, with the full-year FY2021 number at -$95.9 million, down 23.71% from a year prior.
  • Retained Earnings was -$95.9 million for Q4 2021 at Purple Biotech, down from -$77.5 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of -$38.5 million in Q4 2017 to a low of -$95.9 million in Q4 2021.
  • A 5-year average of -$61.0 million and a median of -$49.5 million in 2019 define the central range for Retained Earnings.
  • Peak YoY movement for Retained Earnings: dropped 13.4% in 2019, then crashed 56.54% in 2020.
  • Purple Biotech's Retained Earnings stood at -$38.5 million in 2017, then decreased by 13.52% to -$43.7 million in 2018, then fell by 13.4% to -$49.5 million in 2019, then crashed by 56.54% to -$77.5 million in 2020, then decreased by 23.71% to -$95.9 million in 2021.
  • Per Business Quant, the three most recent readings for PPBT's Retained Earnings are -$95.9 million (Q4 2021), -$77.5 million (Q4 2020), and -$49.5 million (Q4 2019).